Sign In
Buy IBB
$167.50
+3.23 (+1.97%)
At Close: Jun 03, 2026
Why I'm Selling iShares Nasdaq Biotechnology ETF Even When The Outlook Is Promising
05:49am, Wednesday, 17'th Mar 2021
IBB has appreciated 45% since my last article almost a year ago, but it has failed to beat the market in this period. Because IBB invests in the leading healthcare companies in the world, the pipeline
5 ETF Investing Areas for March to Boost Returns
04:40pm, Wednesday, 03'rd Mar 2021
Here we discuss a few ETFs that can enrich investors' portfolio in March amid a strong wave of optimism surrounding the coronavirus vaccine and introduction of another round of fiscal stimulus.
Is This Cheap Cancer-Drug Company a Top Stock to Buy Now?
06:25am, Friday, 19'th Feb 2021
Large biotechs are taking over small-cap companies (and their cancer treatments) left and right. Could this business be the next target?
Illumina Earnings, Forward Guidance Strengthen Biotech ETFs
03:38pm, Friday, 12'th Feb 2021
Biotechnology sector-related exchange traded funds strengthened after Illumina (NasdaqGS: ILMN) announced better-than-expected quarterly earnings and an optimistic 2021 outlook. On Friday, the VanEck
How Will Biotech ETFs React to These Q4 Earnings Releases?
03:54pm, Friday, 05'th Feb 2021
Let's take a look at some ETFs with exposure to major players in the U.S. biotech industry post their fourth-quarter earnings releases amid the coronavirus crisis.
Howard Gold's No-Nonsense Investing: These ‘lucky seven' ETFs left the S&P 500 in the dust in the past decade-plus
07:43am, Thursday, 21'st Jan 2021
Niche and sector exchange traded funds would have made you five times your money.
The Biden portfolio
07:21pm, Wednesday, 20'th Jan 2021
The stocks most likely to get a boost from the new administration. With CNBC's Melissa Lee and the Fast Money traders, Guy Adami, Tim Seymour, Karen Finerman, and Steve Grasso.
A Guide to Biotech ETF Investing Amid the Coronavirus Crisis
02:18pm, Tuesday, 12'th Jan 2021
The biotech space had an impressive run on the bourses in 2020 as the coronavirus pandemic triggered a race to roll out vaccine and treatment.
ETF Areas Thriving During Coronavirus Pandemic
06:48pm, Thursday, 07'th Jan 2021
We highlight some ETF areas that held their ground and gained popularity among investors amid the coronavirus crisis.
iShares Nasdaq Biotechnology ETF: Continuous Innovation For Mankind
01:51pm, Wednesday, 06'th Jan 2021
The iShares Nasdaq Biotechnology ETF includes both COVID-19 and other plays. The ETF is up by 26% during the last year and there are questions around further growth.
Active Traders Look to Biotech for 2021
09:10am, Tuesday, 05'th Jan 2021
Due to lucrative risk/reward setups and heightened fundamental demand, many active traders will be watching biotech stocks.
Wil Nasdaq ETFs Win in 2021 After the Best Year Since 2009?
01:41pm, Monday, 04'th Jan 2021
The Nasdaq clocked double-digit gains for two years in a row in 2020. It may log double-digit gains in 2021 all over again if the virus scenario does not improve as fast as expected.
Get Your Portfolio Christmas-Ready With These ETFs
09:47am, Saturday, 19'th Dec 2020
Here we highlight some ETFs that can help investors make the most of the favorable investing opportunities amid the coronavirus crisis.
Why this health-care strategist says the sector will rally into 2021
02:31pm, Wednesday, 16'th Dec 2020
CNBC's Kelly Evans discusses the healthcare sector as well as biotech and pharma stocks and why the rally in these names can continue into 2021 with Jefferies' Jared Holz.
Biotech ETFs surge on vaccine rollout, Alexion-AstraZeneca tie-up
02:35pm, Monday, 14'th Dec 2020
Biotech exchange-traded funds rallied Monday as the rollout of the coronavirus vaccine across America shed a bullish light on the industry. The First Trust NYSE Arca Biotechnology Index Fund jumped 4%
